TITLE

CONTRACEPTIVE REDESIGN: NEW PROGESTINS/NEW REGIMENS

AUTHOR(S)
Sulak, Patricia J.
PUB. DATE
September 2004
SOURCE
Journal of Family Practice;Sep2004 Contraceptive Co, pS3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Although oral contraceptives (OC) have been in use for more than 40 years, side effects continue to affect compliance. This article examines the traditional OC schedule of administration. An attempt is made to determine whether there is a need for changes in OC regimens, and whether new regimens and/or progestins provide additional benefits for patients. The side effects associated with the standard 21/7-day OC regimen in a prospective study is also investigated.
ACCESSION #
15562803

 

Related Articles

  • Oral contraceptive update: New agents and regimens. Sulak, Patricia J. // Journal of Family Practice;Jul2004 Supplement, Vol. 53, pS5 

    This article discusses how oral contraceptives can offer an excellent strategy to avoid pregnancy and manage or prevent health problems for reproductive-age women. Long-term oral contraceptive use can also reduce the risk for future gynecologic and other health problems. New regimens that...

  • Risk of Blood Clots Higher for Oral Contraceptives With Certain Progestins. Voelker, Rebecca // JAMA: Journal of the American Medical Association;11/23/2011, Vol. 306 Issue 20, p2206 

    The article focuses on a study which examined the link between progestin use in oral contraceptives and the risk of developing venous thromboembolism among women. Subjects were observed by researchers from 2001 to 2009. Results of the study showed that women who used oral contraceptives with...

  • The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology. M. Engman; L. Skoog; G. Söderqvist; K. Gemzell-Danielsson // Human Reproduction;Sep2008, Vol. 23 Issue 9, p2072 

    : BACKGROUND Progestins as well as estrogens have a role in breast cell proliferation and the development of breast cancer. Here, the effect of mifepristone on cell proliferation in human breast tissue in vivo was studied in premenopausal women. : METHODS A group of 30 women, scheduled for...

  • Femulen.  // Royal Society of Medicine: Medicines;2002, p243 

    This article presents information on Femulen, a proprietary, prescription-only preparation which can be used as an oral contraceptive of the progestogen-only pill type and contains etynodiol diacetate. It is available as tablets in a calendar pack. It is manufactured by Pharmacia.

  • Commentary. O'Connor, Vivienne // Evidence Based Medicine;Apr2006, Vol. 11 Issue 2, p53 

    The article presents comments on the results of a study comparing the effectiveness of continuous or extended combination oral contraceptives and monthly cyclic combination oral contraceptives. It has been suggested that less bleeding occurred with higher estrogen or progesterone dose. Bleeding...

  • Review: 6 RCTs show similar efficacy and safely for continuous dosing and 28 day combination contraceptive pills. Edelman, A. B.; Gallo, M. F.; Jensen, J. T. // Evidence Based Medicine;Apr2006, Vol. 11 Issue 2, p53 

    The article focuses on a study comparing the effectiveness of continuous (extended) combination oral contraceptives and monthly cyclic combination oral contraceptives. Randomized controlled trials were used in women of reproductive age. Among the outcomes considered were the bleeding patters,...

  • A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms. Wichianpitaya, Jirath; Taneepanichskul, Surasak // Obstetrics & Gynecology International;2013, p1 

    Objective. To compare the efficacy of low-dose COC containing desogestrel (DSG) with drospirenone (DRSP) in the changes of premenstrual symptoms. Methods. In an open-label randomized controlled trial, 90 women with premenstrual syndrome who required COC were randomly recruited and allocated...

  • Safe and Effective for Long-Term Use. Anderson, F. D. // Fertility Weekly;10/2/2006, p4 

    The article presents a study which explores the safeness and effectiveness of the long-term use of extended-cycle oral contraceptive (OC) called Seasonale. The objective of the study was to assess the findings of the previous clinical trial regarding the effectiveness and safety of Seasonale....

  • Oral contraceptives.  // Reactions Weekly;6/17/2006, Issue 1106, p16 

    Presents cases of benign paroxysmal positional vertigo resulting from the use of oral contraceptives. Types of oral contraceptives used by the patients; Symptoms experienced by the patients after using the oral contraceptives.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics